Drug Contact Time
Drug Contact Time - Related Videos
01:14
Time Course of Drug Effect
0 Views •
2023
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
0 Views •
Cited by 14 •
2016
Current in vitro models for evaluating contact lenses (CLs) and other eye-related applications are severely limited. The presented ocular platform simulates physiological tear flow, tear volume, air exposure and mechanical wear. This system is highly versatile and can be applied to various in vitro analyses with CLs.
01:15
Drug Concentration Versus Time Correlation
0 Views •
2024
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation. Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
01:13
Contact Angle
0 Views •
2023
When a solid is dipped inside a liquid, the liquid surface becomes curved near the contact. For some solid–liquid interfaces, the liquid is pulled up along the solid, while for others, the liquid surface is convex or depressed near the solid surface. This phenomenon can be explained using the concept of cohesive and adhesive forces. The adhesive force is the molecular force between molecules of different materials, that is, between the molecules of the solid and the liquid. The cohesive force...
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
0 Views •
Cited by 2 •
2022
Contact hypersensitivity (CHS) is a murine experimental model of allergic contact dermatitis (ACD). CHS is based on sensitization with reactive hapten by painting the shaved skin of the chest and abdomen, with a subsequent ear skin challenge with a diluted hapten, causing a swelling reaction that is assessed in various ways.
FAQs
Fluid movement, local clearance, and tissue turnover can remove a medication from its target before it fully dissolves, diffuses, or interacts locally. Formulation properties and dosing conditions can therefore change how long the active ingredient remains available. These variables help explain why identical treatments may produce different local exposure and outcomes.
Dissolution and diffusion determine whether a medication can reach tissue components during its available interval. The drug may then interact with local receptors or pathogens before fluid movement, clearance, or tissue turnover removes it. Consequently, contact time links the physical persistence of a treatment with the opportunity for a local biological effect.
Formulation can determine how long the active ingredient remains at the intended surface or tissue under particular dosing conditions. That duration affects the opportunity for dissolution, diffusion, and local interaction. Formulation considerations are therefore important when developing treatments intended for topical, ophthalmic, mucosal, or wound application.
Clinicians can interpret treatment outcomes alongside the conditions that determine how long the medication remains available locally. Therapeutic monitoring may consider whether fluid movement, clearance, tissue turnover, formulation, or dosing conditions altered exposure at the target site. This context can support more informed evaluation of effectiveness and safety.
Contact time is particularly relevant when medication is applied directly to a biological surface or tissue, including topical, ophthalmic, mucosal, and wound treatments. In these settings, local removal processes can influence drug availability before the intended interaction occurs. Assessing contact time helps connect formulation and dosing decisions with observed treatment outcomes.
Development and dosing decisions can account for the interval during which an active ingredient remains available at its intended site. Researchers and clinicians can relate that interval to dissolution, diffusion, local receptor or pathogen interaction, and removal processes. This approach supports evaluation of treatment performance, therapeutic monitoring, and safety in local drug delivery.